The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis
Daniel Canter(Ochsner Medical Center), Bruce Malkowicz(University of Pennsylvania), Meredith Bergey(Brandeis University), David J. Vaughn(University of Pennsylvania), John E. Tomazewski(Hospital of the University of Pennsylvania), Laurie Magerfleisch(Hospital of the University of Pennsylvania), Seema S. Sonnad(University of Pennsylvania), Keith Van Arsdalen, Matthew J. Resnick(Vanderbilt University Medical Center), Thomas J. Guzzo(Hospital of the University of Pennsylvania)
Cited by 39
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
|Journal of Clinical Oncology|2007|799
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688